ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Use of tezepelumab for chronic rhinosinusitis with nasal polyps by eosinophilic endotype: WAYPOINT post-hoc analysis

Study limitation reported by the research below: “ECRS subgroup classification used the Japanese JESREC criteria, which may not translate directly to ECRS definitions used in Western clinical practice.”

Papers